3 completed. 3 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 3 | Completed 3 |
Follow Patient Preference: new trials by email Literature Review of Patient Preference trials Research Report on Patient Preference
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Vildagliptin Versus Liraglutide - Patient Preference After Receiving Both Medications Vildagliptin/ Metformin, Liraglutide, Metformin - Type 2 Diabetes | Phase 4 | Completed | Novartis Pharmaceuticals | 62 | 2012-01-01 | 2017-02-27 |
| Study to Evaluate Effectiveness of Aranesp® Aranesp® - Kidney Disease | Phase 4 | Completed | Amgen | 2011-01-21 | ||
| Aranesp® Monthly Preference Study - 2 Aranesp® - Kidney Disease | Phase 4 | Completed | Amgen | 2008-09-30 |
Kidney Diseases (2) · Renal Insufficiency, Chronic (2) · Diabetes Mellitus, Type 2 (1)
Behavior (3) · Health Behavior (3) · Patient Satisfaction (3) · Treatment Adherence and Compliance (3) · Chronic Disease (2) · Disease Attributes (2) · Female Urogenital Diseases (2) · Female Urogenital Diseases and Pregnancy Complications (2) · Male Urogenital Diseases (2) · Pathologic Processes (2) · Pathological Conditions, Signs and Symptoms (2) · Renal Insufficiency (2) · Urogenital Diseases (2) · Urologic Diseases (2) · Diabetes Mellitus (1)
Darbepoetin alfa (2) · Liraglutide (1) · Metformin (1) · Vildagliptin (1)
Amgen (2) · Novartis Pharmaceuticals (1)
Germany (1)